跳至主要内容
临床试验/IRCT20190103042220N1
IRCT20190103042220N1招募中3 期

The effects of symbiotic supplement containing Bacillus coagulans and fructo oligosaccharide on glycemic index , cardiovascular risk factors and and systemic inflammation in patients with type 2 diabetes

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Willingness to cooperate and complete informed informed consent form • Patients aged 30-70 years • Body mass index = 35 kg / m2 • haveType 2 diabetes • No history of alcohol or alcohol less than 10 grams Per day in women and less than 20 grams per day in men • no pregnancy and lactation • no thyroid gland disorders • no kidney and inflammatory disease • failure to follow weight loss regimens 6 months before the start of the study • no use Slimming drugs (Orlites, Slim Lists) and fat burners, fiber powder • Non-use of glucocorticoids and non-steroidal anti-inflammatory drugs • no use of insulin

排除标准

  • show complications associated with supplementation• No regular use of supplement• Consume less than 80% of supplements in three months

研究者

相似试验